logo
  

Norsk Hydro Says Eivind Kallevik Assumed Role Of CEO

Norsk Hydro ASA (NHYDY.PK), a Norwegian aluminium and renewable energy firm, said on Monday that Eivind Kallevik assumed his role as Chief Executive Officer on May 13.

As announced on March 14, Kallevik has succeeded Hilde Merete Aasheim.

Earlier, Kallevik was Executive Vice President and Head of Hydro's Aluminium Metal business area.

In addition, the company has announced that Trond Olaf Christophersen, Executive Vice President for Corporate Development and interim Chief Financial Officer, will take on the role as CFO.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Microsoft has launched a new category of Windows PCs designed for Artificial Intelligence (AI) that are slated to be the fastest and most intelligent Windows PCs ever built. The Copilot+ PCs come with built-in AI hardware and will support AI features across the operating system. Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, according to the U.S. Food and Drug Administration. The recall was initiated due to the potential for incomplete crimp seals. The company has received one customer complaint for one leaking unit. While reporting financial results for the first quarter on Wednesday, off-price retailer TJX Companies, Inc. (TJX) provided its earnings and comparable store sales outlook for the second quarter and raised earnings outlook for the full-year 2024. For the second quarter, the company now expects earnings...

In this week's video, we highlight Roche's pioneering approach for weight loss and glucose control. Meanwhile, the EMA has taken strict action on certain preterm birth drugs and Bayer has downsized its staff. In a breakthrough for cancer treatment, the FDA has approved a groundbreaking T-cell engager therapy. Amid progress, setbacks emerge as another ALS drug study has faltered, following closely on the heels of Amylyx Pharma's recent decision to withdraw its FDA-approved ALS drug, Relyvrio.

View More Videos
Follow RTT